Hematologic Malignancy
Early T Precursor Lymphoblastic Leukemia/Lymphoma
CI-CAN-00002566Explore in graph →
Hematologic2 active trials
- NCIt
- C199170
Loading cancer entity…
Hematologic Malignancy
CI-CAN-00002566Explore in graph →
Clinical trials
3 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancersTerminated studies (0)
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07012447 | Venetoclax + Azacytidine for Newly Diagnosed ETP-like ALL and T-ALL With Myeloid Mutations | recruiting | Phase 2 | 32 | yuejun LiuOTHER | 1 | Jun 10, 2025 | clinicaltrials |
| NCT06361329 | Comparing the Efficacy of VHAG and Traditional Chemotherapy Regimens in Newly Diagnosed ETP-ALL | recruiting | Phase 3 | 81 | First Affiliated Hospital of Zhejiang UniversityOTHER | 1 | Feb 17, 2025 | clinicaltrials |
| NCT04582487 |
| Advancing Chemical and Genomic Strategies for Relapsed/Refractory T-ALL and ETP-ALL |
| unknown |
| N/A |
| 32 |
| Gruppo Italiano Malattie EMatologiche dell'AdultoOTHER |
| 1 |
| Feb 7, 2024 |
| clinicaltrials |
Data updated 22 days agoSource updated Jun 10, 2025source: clinicaltrials